1. Proposed Quality Performance indicators (QPI’s) for axillary lymphadenectomy in Melanoma. Accepted for publication in EJSO, July 2021

2. Morbidity following thyroid and parathyroid surgery: Results from key performance indicator assessment at a high-volume centre in New Zealand. ANZJS 2021; 91: 1804-1812

3. Contemporary management of  locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy. B Mark Smithers, Robyn PM Saw, David E Gyorki, Richard CW Martin,Victoria Atkinson, Andrew Haydon, Rachel Roberts-Thomson, John F Thompson. ANZJS 2021; 91(2): 3-13

4. Proposed quality performance indicators of sentinel lymph node biopsy for cutaneous Melanoma. ANZJS 2021. Epub ahead of print. PMID: 33956390.

5. A case of cystic lymphatic malformation mimicking acute appendicitis in an adult patient: a rare diagnostic pitfall. M Joret, A Nananyakkra, RCW Martin. BMJ Case Rep 021; 14:e239509

6.Radiological Imaging of Melanoma: A Review to guide clinical practice in New Zealand. NZMJ 2021; 134(1528): 79-87

7. Distinctive populations of human lymph node stromal cells contribute to cancer-associated fibroblasts following melanoma metastasis (Running title: Stromal cells in Melanoma-infiltrated lymph nodes). Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J. Chen, Julie D. McIntosh, Catherine E. Angel, Adam Bartlett, Richard Martin, Jonathan Cebon, Michael A Black, Anna E.S. Brooks, P. Rod Dunbar. Cancer Immunology Research 2020; 8(8): 990-1003

8. Quality Measures in Cervical Lymphadenectomy for cutaneous malignancy by Head and Neck trained General Surgeons. F Nahab, Sita Olek, RCW Martin. NZMJ 2020; 133(1520); 50-60

9. E-referrals and teledermatoscopy grading for melanoma, a successful model of care. AJD 2020 May; 61(2): 147-151

10. Quality assessment of a large primary skin cancer service in Auckland, New Zealand. NZMJ 2020; 133(1509):17-27

11. Sentinel Node Biopsy in 105 high risk cutaneous SCC of the Head and Neck: Results of a multicentre trial. Craig P. Mooney, Richard C. W. Martin, Richard Dirven, Bruce G. Ashford, Kerwin Shannon, Carsten E. Palme, Quan Ngo, James Wykes, Sarah Davies, Kan Gao, Sydney Ch’ng, Tsu-Hui (Hubert) Low, Ruta Gupta, Jonathan R. Clark. Ann Surg Oncol 2019 Dec; 26(13):4481-4488.

12. Body site distribution of squamous cell and basal cell cancer in a high risk New Zealand population. Essa Tawfiq, Mark Elwood, G Rolfe, P Emanual, Richard Martin. Journal of Experimental Dermatology 2019; 6(2): 030

13. WOUND Study: a cost-utility analysis of negative pressure wound therapy following split-skin grafting for lower limb skin cancer. Helen J Ker, Abbas Al-Murrani, Gill Rolfe, Richard CW Martin. Journal of Surgical Research 2019; 253: 308-314

14. Elective Services Productivity and Effectiveness Review: Waitemata DHB Skin Clinic and Procedure Model of Care. February 2018 EPUB. M Broome, K Macfarlane, RCW Martin

15. WOUND trial. A prospective randomised trial of bolster dressing v’s negative pressure suction dressing and early mobilisation for lower limb skin grafts. R Vather, H Hammodat, K Gale, RCW Martin. JPRAS 2018; 71(7): 1100-1102

16. The burden of non-melanoma skin cancer in Auckland, NZ. A Podicherry, P Emanual, I Meredith,  RCW Martin, M Elwood. Australasian Journal of Dermatology 2018; 59 (3): 210-213

17. Epidemiology of Melanoma in Situ in New Zealand. Sam Rice, Richard Martin. NZMJ 2018; 131(1482): 73-79

18. Establishment of a national “complex” BCC database. M Carpenter, RCW Martin. RCW Martin, M Carpenter, G Rolfe, R Carpenter. Clinical Skin. Cancer 2016; 1(2): 82-87

19. Prospective study of sentinel node biopsy for high risk cutaneous squamous cell carcinoma of the head and neck. Sinclair M. Gore, Douglas Shaw, Richard C.W. Martin, Kathryn Roth, Roger Uren, Kan Gao, Sarah Davies, Bruce G. Ashford, Quan Ngo, Kerwin Shannon and Jonathan R. Clark. Head & Neck April 2016; 38: 884–889

20. Successful melanoma triage by virtual lesion clinic (teledermatology). Congalton AT, Oakley AM, Rademaker M, Bramley D, Martin RCW. JEADV 2015 Dec; 29(12): 2423-8

21. Predicting lymph node metastases in cutaneous squamous cell carcinoma: use of a morphological scoring system.  Nicholas J M Agar, Christopher Kirton, Rajan Patel, Richard C W Martin, Neville Angelo, Patrick O Emanuel. NZMJ 2015; 128(1411)

22. Epidemiology of Merkel Cell Carcinoma in New Zealand: A population based study. Robertson JP, Liang ES, Martin RC. B J of Dermatology 2015; 173(3):835–837

23. Standards of Service Provision for Melanoma Patients in New Zealand. RCW Martin, Chairman of Melanoma group, published 2013.

24. Combined cellular blue naevus and trichoepithelioma. Martin RC, Emanuel PO. J Clin Aesthet Dermatol. 2013 Aug; 6(8):35-8.

25. The Management of Cervical Nodes in Cutaneous Melanoma. RCW Martin, K Gao, K Shannon, A Spillane, J Stretch, CJ O’Brien, JF Thompson. Ann Surg Oncol 2012 Nov; 19(12): 3926-32.

26. Malignant Melanoma amongst Maori and New Zealand Europeans, 2000-2004.T Hore, E Robinson, RCW Martin. WJS 2010; 34(8): 178801792

27. Cutaneous Melanoma in New Zealand: 2000-2004. Jennifer JC Liang, Elizabeth Robinson and Richard CW Martin. ANZJS 2010; 80(5): 321-316.

28. So-called “malignant blue naevus” – a clinico-pathological study of 23 cases. Richard C. W. Martin, Rajmohan Murali, Richard A. Scolyer, Patrick, Fitzgerald, Margaret H. Coleman and John F. Thompson. Cancer 2009; 115(13): 2949-2955.

29. Efficacy of repeat Positron Emission Tomography (PET) in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. RCW Martin, M Fulham, CJ O’Brien et al. Head Neck. 2009; 31(2): 244-50.

30. Adjuvant Postoperative Radiotherapy to Cervical Lymph Nodes in Cutaneous Melanoma: Is there Any Benefit for High Risk Patients? Marc D Montcrief, Richard Martin, Christopher J. O’Brien, Kerwin F Shannon, Jonathon R Clark, Kan Gao, William M McCarthy and John F Thompson. Annals of Surgical Oncology 2008; 15(11): 3022-3027.

31. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. A Makris, C Thornton, S Thompson, J Thompson, R Martin, P Mckenzie, R Ogle, R Waugh, A Hennessy. Kidney International 2007; 71(10): 977-84.

32. The role of Sentinel Node Biopsy in high risk Cutaneous Squamous Cell Carcinoma. R Martin. Master’s thesis, University of Sydney, 2007

33. Ossified adrenocortical adenoma: an unusual radiological and morphological appearance. EDM Fong, R Martin, IM Cranshaw, A Morrine, JHF Shaw. ANZJS 2005; 75(9): 835

34. Necrotising Fasciitis in South Auckland. A Tiu, RCW Martin, A MacCormick, A Hill. ANZJS 2005; 75(1-2): 32-4

35. Allergic reactions to enoxaparin and heparin: a case report and review of the literature. Albert Tiu, Jia-Min Pang, Richard Martin, Neil Officer. NZMJ 2004; 117-120

36. Cutaneous Melanoma in Caucasian New Zealanders. RCW Martin, E Robinson. ANZJS 2004; 74: 233-7

37. Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alonewith triple modality localization. RCW Martin, W Myer-Rochow, CR Harman. ANZJS 2003; 73(10):815-818

BOOK CHAPTERS

1. Non-melanoma skin cancer. RCW Martin, W Cooper, CS Lee, CJ O’Brien. Head and Neck Surgery and Oncology: Principles and Practice. 2006 BC Decker online textbook. www.bcdecker.com

2. Stell and Maran’s Text Book of Head and Neck Surgery and Oncology, 5th Edition, 2012. Hodder and Arnold. Chapter 36. Non melanoma and melanoma skin cancer. RCW Martin, J Clark.

3. Treating advanced Basal Cell Carcinoma in NZ. Research review educational series, 2014. www.researchreview.co.nz

‍